Back
Roivant Sciences Vs. Akari Therapeutics PLC Industry Stock Comparison
Buy
55
ROIV
Roivant Sciences
Last Price:
11.23
Seasonality Move:
18%
Sell
40
AKTX
Akari Therapeutics PLC
Last Price:
1.53
Seasonality Move:
-5.4%
Buy
55
Roivant Sciences (ROIV)
is a Buy
Is Roivant Sciences a Buy, Sell or Hold?
- The current Roivant Sciences [ROIV] share price is $11.23. The Score for ROIV is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- ROIV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Akari Therapeutics PLC (AKTX)
is a Sell
Is Akari Therapeutics PLC a Buy, Sell or Hold?
- The current Akari Therapeutics PLC [AKTX] share price is $1.52. The Score for AKTX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- AKTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ROIV Stock Price Chart
What is Roivant Sciences's stock price today?
-
The Roivant Sciences share price today is $11.23
The current trend is moderately bullish and ROIV is experiencing slight buying pressure.
AKTX Stock Price Chart
What is Akari Therapeutics PLC's stock price today?
-
The Akari Therapeutics PLC share price today is $1.52
The current trend is relatively stagnant and AKTX is experiencing slight selling pressure.
ROIV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.12 | Buy |
| Relative Strength Index (14 RSI): | 52.25 | Buy |
| Chaikin Money Flow: | 731262 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.72 - 11.38) | Buy |
| Bollinger Bands (100): | (10.38 - 11.46) | Buy |
AKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 52.73 | Buy |
| Chaikin Money Flow: | -6718 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.19 - 1.55) | Buy |
| Bollinger Bands (100): | (1.47 - 2.67) | Sell |
ROIV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.28 | Sell |
| 20-day SMA: | 11.17 | Buy |
| 50-day SMA: | 10.86 | Buy |
| 200-day SMA: | 10.63 | Buy |
| 8-day EMA: | 11.3 | Sell |
| 20-day EMA: | 11.19 | Buy |
| 50-day EMA: | 11.02 | Buy |
| 200-day EMA: | 10.42 | Buy |
AKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.52 | Buy |
| 20-day SMA: | 1.42 | Buy |
| 50-day SMA: | 1.55 | Sell |
| 200-day SMA: | 2.82 | Sell |
| 8-day EMA: | 1.49 | Buy |
| 20-day EMA: | 1.46 | Buy |
| 50-day EMA: | 1.62 | Sell |
| 200-day EMA: | 3.04 | Sell |
Roivant Sciences Earnings Growth & ROIV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.22 per share.
Akari Therapeutics PLC Earnings Growth & AKTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and a decrease next year of $0.00 per share.
Roivant Sciences Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akari Therapeutics PLC Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||